APA (7th ed.) Citation

S, V., GD, B., DW, H., & Z, G. (2022). Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group. Acta medica academica, 51(3), 217. https://doi.org/10.5644/ama2006-124.392

Chicago Style (17th ed.) Citation

S, Vranic, Basu GD, Hall DW, and Gatalica Z. "Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group." Acta Medica Academica 51, no. 3 (2022): 217. https://doi.org/10.5644/ama2006-124.392.

MLA (9th ed.) Citation

S, Vranic, et al. "Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group." Acta Medica Academica, vol. 51, no. 3, 2022, p. 217, https://doi.org/10.5644/ama2006-124.392.